<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">33904964</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>03</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1432-1173</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>73</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete</Title>
          <ISOAbbreviation>Hautarzt</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Atypical keloids with an unusual myofibroblastic differentiation in a patient with acne vulgaris].</ArticleTitle>
        <Pagination>
          <StartPage>216</StartPage>
          <EndPage>219</EndPage>
          <MedlinePgn>216-219</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00105-021-04815-3</ELocationID>
        <Abstract>
          <AbstractText>We present the case of a patient with a discreet acne and multiple keloids in the area of the upper trunk, histologically showing an unusual myofibroblastic differentiation. So far, the clinical course shows a poor response to the treatment, including cryotherapy, intralesional corticosteroid injections, occlusive silicone dressings and dye laser.</AbstractText>
          <CopyrightInformation>© 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Scheiba</LastName>
            <ForeName>N</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Haut- und Laserzentrum Heidelberg, Bergheimer Str. 56a, 69115, Heidelberg, Deutschland. dr.n.scheiba@durani-facharzt.de.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hartschuh</LastName>
            <ForeName>W</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Haut- und Laserzentrum Heidelberg, Bergheimer Str. 56a, 69115, Heidelberg, Deutschland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Hautklinik des Universitätsklinikums Heidelberg, Im Neuenheimer Feld 440, 69120, Heidelberg, Deutschland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>ger</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Atypische, Myofibroblasten-reiche Keloide im Rahmen einer Acne vulgaris.</VernacularTitle>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>04</Month>
          <Day>27</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Hautarzt</MedlineTA>
        <NlmUniqueID>0372755</NlmUniqueID>
        <ISSNLinking>0017-8470</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000152" MajorTopicYN="Y">Acne Vulgaris</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017439" MajorTopicYN="Y">Cicatrix, Hypertrophic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017679" MajorTopicYN="N">Cryotherapy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015552" MajorTopicYN="N">Injections, Intralesional</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007627" MajorTopicYN="Y">Keloid</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <OtherAbstract Type="Publisher" Language="ger">
        <AbstractText>Wir berichten über eine Patientin mit multiplen atypischen Keloiden an Dekolleté und oberem Rücken im Rahmen einer eher dezenten Acne vulgaris. Histologisch zeigte sich eine ungewöhnliche Myofibroblasten-reiche Differenzierung. Bisherige Therapieversuche mittels Kryotherapie, teils in Kombination mit Triamcinolonacetonid-Injektionen, Silikonfolien und Farbstofflaser zeigten insgesamt ein schlechtes klinisches Ansprechen.</AbstractText>
        <CopyrightInformation>© 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.</CopyrightInformation>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cicatrix</Keyword>
        <Keyword MajorTopicYN="N">Cryotherapy</Keyword>
        <Keyword MajorTopicYN="N">Histology</Keyword>
        <Keyword MajorTopicYN="N">Keloid</Keyword>
        <Keyword MajorTopicYN="N">Myofibromatosis</Keyword>
        <Keyword MajorTopicYN="N">Scar therapy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>27</Day>
          <Hour>12</Hour>
          <Minute>18</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33904964</ArticleId>
        <ArticleId IdType="doi">10.1007/s00105-021-04815-3</ArticleId>
        <ArticleId IdType="pii">10.1007/s00105-021-04815-3</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>Literatur</Title>
        <Reference>
          <Citation>Aschoff R (2014) Therapie hypertropher Narben und Keloide [Therapy of hypertrophic scars and keloids]. Hautarzt 65(12):1067–1077</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00105-014-3546-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chipev C, Simman R, Hatch G et al (2000) Myofibroblast phenotype and apoptosis in keloid and palmar fibroblasts in vitro. Cell Death Differ 7:166–176</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.cdd.4400605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Layton AM, Henderson CA, Cunliffe WJ (1994) A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol 19:303–308</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2230.1994.tb01200.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee JY, Yang CC, Chao SC, Wong TW (2004) Histopathological differential diagnosis of keloid and hypertrophic scar. Am J Dermatopathol 26(5):379–384</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00000372-200410000-00006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Limandjaja GC, Niessen FB, Scheper RJ, Gibbs S (2020) The keloid disorder: heterogeneity, histopathology, mechanisms and models. Front Cell Dev Biol 8:360</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcell.2020.00360</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meister P (1998) Myofibroblasten Übersicht und Ausblick. Pathologe 19:187–193</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s002920050272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mentzel T, Fletcher CDM (1997) The emerging role of myofibroblasts in soft tissue neoplasia. Am J Clin Pathol 107:2–5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ajcp/107.1.2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nast A et al (2020) S2k-Leitlinie Therapie pathologischer Narben (hypertrophe Narben und Keloide) – Update 2020. J Dtsch Dermatol Ges 19(2):312–327. https://doi.org/10.1111/ddg.14279</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ddg.14279</ArticleId>
            <ArticleId IdType="pubmed">33015930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poetschke J, Gauglitz GG (2016) Current options for the treatment of pathological scarring. J Dtsch Dermatol Ges 14(5):467–477</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27119466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tani M, Komura A, Ichihashi M (1997) Dermatomyofibroma (Plaqueförmige Dermale Fibromatose). J Dermatol 24(12):793–797</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1346-8138.1997.tb02329.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolfram D, Tzankov A, Pülzl P, Piza-Katzer H (2009) Hypertrophic scars and keloids—a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg 35(2):171–181</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1524-4725.2008.34406.x</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
